Pharmaceutical Testing Services Market
Pharmaceutical Testing Services Market
The global pharmaceutical testing services market size is calculated at US$ 4.27 Bn in 2024, grew to US$ 4.72 billion in 2025, and is projected to reach around US$ 11.58 billion by 2034. The market is expanding at a CAGR of 10.54% between 2025 and 2034.
Report ID: 10002
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD US$ 4.27 Bn
Forecast Year,
USD US$ 11.58 Bn
CAGR, 2025 -
10.54
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Pharmaceutical Testing Services Market Size Analysis
Pharmaceutical Testing Services Market Size By Service Type 2024 to 2034 (USD )
| Service Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analytical Testing Services | 1.49 | 1.64 | 1.81 | 1.98 | 2.18 | 2.40 | 2.63 | 2.89 | 3.18 | 3.49 | 3.84 |
| Bioanalytical Testing Services | 0.85 | 0.95 | 1.06 | 1.19 | 1.33 | 1.48 | 1.65 | 1.84 | 2.06 | 2.29 | 2.56 |
| Microbiology Testing Services | 0.64 | 0.71 | 0.79 | 0.87 | 0.97 | 1.08 | 1.19 | 1.32 | 1.47 | 1.63 | 1.80 |
| Material Characterization | 0.43 | 0.48 | 0.53 | 0.59 | 0.66 | 0.74 | 0.83 | 0.92 | 1.03 | 1.15 | 1.28 |
| Environmental Monitoring | 0.34 | 0.38 | 0.43 | 0.48 | 0.54 | 0.60 | 0.67 | 0.75 | 0.84 | 0.94 | 1.05 |
| Others | 0.51 | 0.56 | 0.60 | 0.65 | 0.70 | 0.76 | 0.82 | 0.88 | 0.95 | 1.03 | 1.11 |
| Total | 4.27 | 4.72 | 5.22 | 5.77 | 6.38 | 7.05 | 7.79 | 8.61 | 9.52 | 10.52 | 11.63 |
Pharmaceutical Testing Services Market Size By Molecule Type 2024 to 2034 (USD )
| Molecule Type | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Small Molecules | 2.35 | 2.56 | 2.80 | 3.05 | 3.33 | 3.63 | 3.96 | 4.31 | 4.70 | 5.12 | 5.58 |
| Large Molecules | 1.62 | 1.83 | 2.07 | 2.33 | 2.63 | 2.96 | 3.33 | 3.75 | 4.23 | 4.76 | 5.35 |
| Others | 0.30 | 0.33 | 0.36 | 0.39 | 0.42 | 0.46 | 0.50 | 0.54 | 0.59 | 0.64 | 0.70 |
| Total | 4.27 | 4.72 | 5.22 | 5.77 | 6.38 | 7.05 | 7.79 | 8.61 | 9.52 | 10.52 | 11.63 |
Pharmaceutical Testing Services Market Size By Phase 2024 to 2034 (USD )
| Phase | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Preclinical Phase | 0.94 | 1.05 | 1.17 | 1.30 | 1.45 | 1.62 | 1.81 | 2.02 | 2.25 | 2.50 | 2.79 |
| Clinical Phase | 2.05 | 2.26 | 2.48 | 2.73 | 3.01 | 3.31 | 3.65 | 4.01 | 4.42 | 4.86 | 5.35 |
| Commercial/Manufacturing Phase | 1.28 | 1.42 | 1.57 | 1.73 | 1.91 | 2.11 | 2.34 | 2.58 | 2.86 | 3.16 | 3.49 |
| Total | 4.27 | 4.72 | 5.22 | 5.77 | 6.38 | 7.05 | 7.79 | 8.61 | 9.52 | 10.52 | 11.63 |
Pharmaceutical Testing Services Market Size By End-Use 2024 to 2034 (USD )
| End-Use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmaceutical Companies | 1.71 | 1.87 | 2.05 | 2.24 | 2.45 | 2.68 | 2.93 | 3.20 | 3.50 | 3.83 | 4.19 |
| Biopharmaceutical Companies | 1.28 | 1.44 | 1.61 | 1.80 | 2.02 | 2.26 | 2.52 | 2.82 | 3.16 | 3.54 | 3.96 |
| Contract Research Organizations (CROs) | 0.77 | 0.85 | 0.95 | 1.06 | 1.17 | 1.30 | 1.45 | 1.61 | 1.79 | 1.99 | 2.21 |
| Academic & Research Institutions | 0.30 | 0.33 | 0.37 | 0.40 | 0.45 | 0.49 | 0.55 | 0.60 | 0.67 | 0.74 | 0.81 |
| Others | 0.21 | 0.23 | 0.25 | 0.27 | 0.29 | 0.32 | 0.34 | 0.37 | 0.40 | 0.43 | 0.47 |
| Total | 4.27 | 4.72 | 5.22 | 5.77 | 6.38 | 7.05 | 7.79 | 8.61 | 9.52 | 10.52 | 11.63 |
Pharmaceutical Testing Services Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.54 | 1.69 | 1.85 | 2.02 | 2.22 | 2.43 | 2.66 | 2.92 | 3.20 | 3.50 | 3.84 |
| Europe | 1.20 | 1.31 | 1.44 | 1.58 | 1.73 | 1.90 | 2.09 | 2.29 | 2.51 | 2.76 | 3.02 |
| Asia-Pacific | 1.15 | 1.30 | 1.46 | 1.64 | 1.85 | 2.08 | 2.34 | 2.63 | 2.95 | 3.31 | 3.72 |
| Latin America | 0.21 | 0.24 | 0.26 | 0.29 | 0.32 | 0.35 | 0.39 | 0.43 | 0.48 | 0.53 | 0.58 |
| Middle East & Africa | 0.17 | 0.19 | 0.21 | 0.23 | 0.26 | 0.28 | 0.31 | 0.34 | 0.38 | 0.42 | 0.47 |
| Total | 4.27 | 4.72 | 5.22 | 5.77 | 6.38 | 7.05 | 7.79 | 8.61 | 9.52 | 10.52 | 11.63 |
Pharmaceutical Testing Services Market Size Global Market 2024 to 2034 (USD )
| Global Market | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Market Size (USD Bn) | 4.27 | 4.72 | 5.22 | 5.77 | 6.38 | 7.05 | 7.79 | 8.61 | 9.52 | 10.52 | 11.63 |
Pharmaceutical Testing Services Market
Pharmaceutical Testing Services Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
